BIO Financial Facts

Net income per share diluted attributable to Bio-Rad: 0.61
Foreign exchange losses, net: 3.81M
See Full Income Statement

Total current liabilities: 416.88M
Income and other taxes payable: 31.93M
See Full Balance Sheet

Bio-Rad Laboratories, Inc. (BIO) Earnings

  |   Expand Research on BIO
Next EPS Date 8/6/15 EPS Growth Rate -28.4%
Average EPS % Beat Rate +14.9% Revenue Growth Rate -7.8%
Average % Move 1-Wk after EPS +5.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/6/15 Q215 N/A$0.78 N/A N/A$494.85M N/A N/A N/A
5/5/15 Q115 $0.61$0.33 +$0.28$472.8M$474.6M N/A Details
2/26/15 Q414 $1.34$1.18 +$0.16$598.2M$593.41M N/A Details
11/4/14 Q314 $0.40$0.86 -$0.46$530.6M$525.4M N/A Details
8/5/14 Q214 $1.09$0.95 +$0.14$536.8M$537.58M N/A Details
5/6/14 Q114 $0.23$0.80 -$0.57$509M$515M N/A Details
2/27/14 Q413 $1.51$1.42 +$0.09$602.6M$586.67M N/A Details
11/7/13 Q313 -$0.25$0.91 -$1.16$505.07M$529.02M N/A Details